AKASH GARG: Open Payments
NPI 1033671615 · PASADENA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$706 in 34 payments from 10 companies in 2025. Trend: 2023 $916 · 2024 $974 · 2025 $706
Food & beverage: $706
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $167 |
| AstraZeneca Pharmaceuticals LP | 6 | $105 |
| Astellas Pharma US Inc | 4 | $102 |
| Amgen Inc. | 5 | $80 |
| ABBVIE INC. | 3 | $56 |
| Lilly USA, LLC | 2 | $52 |
| PFIZER INC. | 2 | $43 |
| Exact Sciences Corporation | 2 | $43 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
Products named: Veozah, OTEZLA, MOUNJARO, Rybelsus, Ozempic, Wegovy, ELIQUIS, Cologuard Collection Kit.
Industry payments across MD — which companies pay providers there.
